rs4747195

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022124.6(CDH23):​c.7139C>T​(p.Pro2380Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.287 in 1,613,748 control chromosomes in the GnomAD database, including 70,103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P2380P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.28 ( 6316 hom., cov: 33)
Exomes 𝑓: 0.29 ( 63787 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

7
3
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 7.88

Publications

44 publications found
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
CDH23 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003720373).
BP6
Variant 10-71799195-C-T is Benign according to our data. Variant chr10-71799195-C-T is described in ClinVar as Benign. ClinVar VariationId is 46028.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.515 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.7139C>T p.Pro2380Leu missense_variant Exon 51 of 70 ENST00000224721.12 NP_071407.4 Q9H251-1Q6P152
CDH23NM_001171933.1 linkc.419C>T p.Pro140Leu missense_variant Exon 4 of 23 NP_001165404.1 Q9H251-7
CDH23NM_001171934.1 linkc.419C>T p.Pro140Leu missense_variant Exon 4 of 22 NP_001165405.1 Q9H251-9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.7139C>T p.Pro2380Leu missense_variant Exon 51 of 70 5 NM_022124.6 ENSP00000224721.9 Q9H251-1

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
42635
AN:
151990
Hom.:
6312
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.248
Gnomad AMI
AF:
0.382
Gnomad AMR
AF:
0.329
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.532
Gnomad SAS
AF:
0.244
Gnomad FIN
AF:
0.345
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.260
GnomAD2 exomes
AF:
0.308
AC:
76764
AN:
249150
AF XY:
0.296
show subpopulations
Gnomad AFR exome
AF:
0.246
Gnomad AMR exome
AF:
0.428
Gnomad ASJ exome
AF:
0.210
Gnomad EAS exome
AF:
0.530
Gnomad FIN exome
AF:
0.347
Gnomad NFE exome
AF:
0.269
Gnomad OTH exome
AF:
0.281
GnomAD4 exome
AF:
0.288
AC:
421080
AN:
1461638
Hom.:
63787
Cov.:
37
AF XY:
0.284
AC XY:
206338
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.248
AC:
8290
AN:
33478
American (AMR)
AF:
0.417
AC:
18648
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.212
AC:
5545
AN:
26136
East Asian (EAS)
AF:
0.575
AC:
22840
AN:
39698
South Asian (SAS)
AF:
0.227
AC:
19603
AN:
86252
European-Finnish (FIN)
AF:
0.345
AC:
18411
AN:
53402
Middle Eastern (MID)
AF:
0.159
AC:
916
AN:
5768
European-Non Finnish (NFE)
AF:
0.278
AC:
309564
AN:
1111818
Other (OTH)
AF:
0.286
AC:
17263
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
16477
32954
49431
65908
82385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10694
21388
32082
42776
53470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.280
AC:
42650
AN:
152110
Hom.:
6316
Cov.:
33
AF XY:
0.284
AC XY:
21138
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.248
AC:
10295
AN:
41494
American (AMR)
AF:
0.330
AC:
5040
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
739
AN:
3472
East Asian (EAS)
AF:
0.532
AC:
2740
AN:
5152
South Asian (SAS)
AF:
0.244
AC:
1173
AN:
4814
European-Finnish (FIN)
AF:
0.345
AC:
3656
AN:
10584
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.266
AC:
18078
AN:
67982
Other (OTH)
AF:
0.258
AC:
545
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1572
3144
4716
6288
7860
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
15195
Bravo
AF:
0.284
TwinsUK
AF:
0.290
AC:
1076
ALSPAC
AF:
0.280
AC:
1080
ESP6500AA
AF:
0.240
AC:
966
ESP6500EA
AF:
0.261
AC:
2173
ExAC
AF:
0.299
AC:
36197
Asia WGS
AF:
0.348
AC:
1210
AN:
3478
EpiCase
AF:
0.253
EpiControl
AF:
0.256

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 12, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 08, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 27, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1D Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive nonsyndromic hearing loss 12 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1 Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Retinitis pigmentosa-deafness syndrome Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.34
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.15
T;T;.;.
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D;D;D;D
MetaRNN
Benign
0.0037
T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Pathogenic
2.9
.;M;.;.
PhyloP100
7.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-9.5
.;.;.;D
REVEL
Benign
0.26
Sift
Uncertain
0.0090
.;.;.;D
Sift4G
Pathogenic
0.0
D;.;D;D
Polyphen
1.0
.;D;.;.
Vest4
0.67
MPC
0.31
ClinPred
0.068
T
GERP RS
5.5
Varity_R
0.89
gMVP
0.72
Mutation Taster
=30/70
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4747195; hg19: chr10-73558952; COSMIC: COSV56452490; API